Retrospective Analysis of Vaccination Status and Predominant Viral Variants in Patients Hospitalized with COVID-19 in Reus, Spain.


Journal

Viruses
ISSN: 1999-4915
Titre abrégé: Viruses
Pays: Switzerland
ID NLM: 101509722

Informations de publication

Date de publication:
30 03 2023
Historique:
received: 21 02 2023
revised: 20 03 2023
accepted: 28 03 2023
medline: 1 5 2023
pubmed: 28 4 2023
entrez: 28 4 2023
Statut: epublish

Résumé

SARS-CoV-2 infection in already-vaccinated individuals is still possible and may require hospitalization. The aim of the present study was to evaluate the clinical evolution of patients with COVID-19 admitted to a public hospital. The outcomes were assessed in relation to the predominant viral variant and the vaccination status. This retrospective study was performed on 1295 COVID-19-positive patients who attended a 352-bed university hospital between 2021 and 2022. Clinical variables and vaccination status were recorded. Of the patients, 799 had not been vaccinated (NV, 61.7%), 449 were partially vaccinated (PV, 34.7%), and 47 were completely vaccinated (CV, 3.6%). The mean age of the CV patients was significantly higher than that of PV and NV. Additionally, they had higher percentages of chronic diseases. The outcomes depended on age but not on vaccination status. There were 209 patients admitted during the Omicron-infection period, of whom 70 (33.5%) were NV, 135 (64.6%) were PV, and 4 (1.9%) were CV. In conclusion, correct vaccination greatly reduces the risk of acquiring severe COVID-19. Partial vaccination does not guarantee protection of the population. This highlights the need for continuous vaccination promotion with all recommended doses, while also investigating alternative treatments for those patients who do not respond to the vaccines.

Identifiants

pubmed: 37112865
pii: v15040886
doi: 10.3390/v15040886
pmc: PMC10143314
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

BMJ. 2022 Mar 9;376:e069761
pubmed: 35264324
JAMA. 2021 Nov 23;326(20):2043-2054
pubmed: 34734975
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):118-124
pubmed: 35085218
Clin Microbiol Infect. 2022 Apr;28(4):612.e1-612.e7
pubmed: 34826623
MMWR Morb Mortal Wkly Rep. 2022 Dec 30;71(5152):1625-1630
pubmed: 36580424
MMWR Morb Mortal Wkly Rep. 2022 Jul 08;71(27):878-884
pubmed: 35797216
Arch Public Health. 2022 Sep 2;80(1):200
pubmed: 36050781
Viruses. 2022 Oct 17;14(10):
pubmed: 36298839
Lancet. 2022 Apr 2;399(10332):1303-1312
pubmed: 35305296
BMJ. 2022 Oct 11;379:e072065
pubmed: 36220174
Lancet Healthy Longev. 2022 Sep;3(9):e589-e598
pubmed: 35935474
Lancet. 2021 Jun 26;397(10293):2461-2462
pubmed: 34139198
Clin Microbiol Infect. 2022 Dec;28(12):1629-1635
pubmed: 35779764
BMJ. 2021 Apr 16;373:n1000
pubmed: 33863709
Lancet. 2022 Apr 23;399(10335):1618-1624
pubmed: 35397851
Ann Intern Med. 1992 Dec 15;117(12):1003-9
pubmed: 1443968
Sci Rep. 2022 Oct 17;12(1):17384
pubmed: 36253391
Lancet Infect Dis. 2022 Jul;22(7):959-966
pubmed: 35468332
MMWR Morb Mortal Wkly Rep. 2022 Aug 26;71(34):1085-1091
pubmed: 36006841
Clin Microbiol Infect. 2021 Nov;27(11):1652-1657
pubmed: 34245907
JAMA Intern Med. 2022 Oct 1;182(10):1071-1081
pubmed: 36074486
PLoS One. 2022 Jul 15;17(7):e0270485
pubmed: 35839210
J Investig Med. 2022 Aug;70(6):1429-1432
pubmed: 35768140
Lancet Infect Dis. 2022 Jan;22(1):35-42
pubmed: 34461056
N Engl J Med. 2021 Jul 22;385(4):320-329
pubmed: 34192428

Auteurs

Simona Iftimie (S)

Department of Internal Medicine, Hospital Universitari de Sant Joan, Institut d'Investigació Sanitària Pere Virgili, Department of Medicine and Surgery, Universitat Rovira i Virgili, Av. Dr. Josep Laporte 2, 43204 Reus, Spain.

Ana F López-Azcona (AF)

Department of Internal Medicine, Hospital Universitari de Sant Joan, Institut d'Investigació Sanitària Pere Virgili, Department of Medicine and Surgery, Universitat Rovira i Virgili, Av. Dr. Josep Laporte 2, 43204 Reus, Spain.

María José Lozano-Olmo (MJ)

Department of Internal Medicine, Hospital Universitari de Sant Joan, Institut d'Investigació Sanitària Pere Virgili, Department of Medicine and Surgery, Universitat Rovira i Virgili, Av. Dr. Josep Laporte 2, 43204 Reus, Spain.

Àngels Naval-Ferrando (À)

Department of Internal Medicine, Hospital Universitari de Sant Joan, Institut d'Investigació Sanitària Pere Virgili, Department of Medicine and Surgery, Universitat Rovira i Virgili, Av. Dr. Josep Laporte 2, 43204 Reus, Spain.

Vicent Domingo-Cortés (V)

Department of Internal Medicine, Hospital Universitari de Sant Joan, Institut d'Investigació Sanitària Pere Virgili, Department of Medicine and Surgery, Universitat Rovira i Virgili, Av. Dr. Josep Laporte 2, 43204 Reus, Spain.

Helena Castañé (H)

Unitat de Recerca Biomèdica, Hospital Universitari de Sant Joan, Institut d'Investigació Sanitària Pere Virgili, Department of Medicine and Surgery, Universitat Rovira i Virgili, Av. Dr. Josep Laporte 2, 43204 Reus, Spain.

Andrea Jiménez-Franco (A)

Unitat de Recerca Biomèdica, Hospital Universitari de Sant Joan, Institut d'Investigació Sanitària Pere Virgili, Department of Medicine and Surgery, Universitat Rovira i Virgili, Av. Dr. Josep Laporte 2, 43204 Reus, Spain.

Anna Hernández-Aguilera (A)

Department of Pathology, Hospital Universitari de Sant Joan, Institut d'Investigació Sanitària Pere Virgili, Av. Dr. Josep Laporte 2, 43204 Reus, Spain.

Carmen Guilarte (C)

Department of Pathology, Hospital Universitari de Sant Joan, Institut d'Investigació Sanitària Pere Virgili, Av. Dr. Josep Laporte 2, 43204 Reus, Spain.

Francesc Riu (F)

Department of Pathology, Hospital Universitari de Sant Joan, Institut d'Investigació Sanitària Pere Virgili, Av. Dr. Josep Laporte 2, 43204 Reus, Spain.

Jordi Camps (J)

Unitat de Recerca Biomèdica, Hospital Universitari de Sant Joan, Institut d'Investigació Sanitària Pere Virgili, Department of Medicine and Surgery, Universitat Rovira i Virgili, Av. Dr. Josep Laporte 2, 43204 Reus, Spain.

Jorge Joven (J)

Unitat de Recerca Biomèdica, Hospital Universitari de Sant Joan, Institut d'Investigació Sanitària Pere Virgili, Department of Medicine and Surgery, Universitat Rovira i Virgili, Av. Dr. Josep Laporte 2, 43204 Reus, Spain.

Antoni Castro (A)

Department of Internal Medicine, Hospital Universitari de Sant Joan, Institut d'Investigació Sanitària Pere Virgili, Department of Medicine and Surgery, Universitat Rovira i Virgili, Av. Dr. Josep Laporte 2, 43204 Reus, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH